Literature DB >> 8360587

Recent developments in catalytic antibodies.

J D Stewart1, S J Benkovic.   

Abstract

Mesh：

Substances：

Year:  1993        PMID： 8360587     DOI： 10.3109/08830189309061698

Source DB:  PubMed          Journal:  Int Rev Immunol        ISSN： 0883-0185            Impact factor:   5.311


× No keyword cloud information.
  10 in total

Review 1.  Dissection of an antibody-catalyzed reaction.

Authors:  J D Stewart; J F Krebs; G Siuzdak; A J Berdis; D B Smithrud; S J Benkovic
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-02       Impact factor: 11.205

2.  Comparison of antibodies hydrolyzing myelin basic protein from the cerebrospinal fluid and serum of patients with multiple sclerosis.

Authors:  Visilii B Doronin; Taisiya A Parkhomenko; Massimiliano Castellazzi; Marina Padroni; Michela Pastore; Valentina N Buneva; Enrico Granieri; Georgy A Nevinsky
Journal:  PLoS One       Date:  2014-09-29       Impact factor: 3.240

3.  Changes in haematopoietic progenitor colony differentiation and proliferation and the production of different abzymes in EAE mice treated with DNA.

Authors:  Kseniya S Aulova; Ludmila B Toporkova; Julia A Lopatnikova; Alina A Alshevskaya; Sergei V Sennikov; Valentina N Buneva; Thomas Budde; Sven G Meuth; Nelly A Popova; Irina A Orlovskaya; Georgy A Nevinsky
Journal:  J Cell Mol Med       Date:  2017-08-05       Impact factor: 5.310

4.  Changes in cell differentiation and proliferation lead to production of abzymes in EAE mice treated with DNA-Histone complexes.

Authors:  Kseniya S Aulova; Ludmila B Toporkova; Julia A Lopatnikova; Alina A Alshevskaya; Sergey E Sedykh; Valentina N Buneva; Thomas Budde; Sven G Meuth; Nelly A Popova; Irina A Orlovskaya; Georgy A Nevinsky
Journal:  J Cell Mol Med       Date:  2018-09-28       Impact factor: 5.310

5.  Increase in Autoantibodies-Abzymes with Peroxidase and Oxidoreductase Activities in Experimental Autoimmune Encephalomyelitis Mice during the Development of EAE Pathology.

Authors:  Anna S Tolmacheva; Kseniya S Aulova; Andrey E Urusov; Irina A Orlovskaya; Georgy A Nevinsky
Journal:  Molecules       Date:  2021-04-04       Impact factor: 4.411

Review 6.  Essential Protective Role of Catalytically Active Antibodies (Abzymes) with Redox Antioxidant Functions in Animals and Humans.

Authors:  Anna S Tolmacheva; Georgy A Nevinsky
Journal:  Int J Mol Sci       Date:  2022-03-31       Impact factor: 5.923

7.  Comparison of DNA-hydrolyzing antibodies from the cerebrospinal fluid and serum of patients with multiple sclerosis.

Authors:  Taisiya A Parkhomenko; Vasilii B Doronin; Massimiliano Castellazzi; Marina Padroni; Michela Pastore; Valentina N Buneva; Enrico Granieri; Georgy A Nevinsky
Journal:  PLoS One       Date:  2014-04-15       Impact factor: 3.240

8.  Comparison of Antibodies with Amylase Activity from Cerebrospinal Fluid and Serum of Patients with Multiple Sclerosis.

Authors:  Vasilii B Doronin; Taisiya A Parkhomenko; Massimiliano Castellazzi; Edward Cesnik; Valentina N Buneva; Enrico Granieri; Georgy A Nevinsky
Journal:  PLoS One       Date:  2016-05-19       Impact factor: 3.240

9.  Changes in different parameters, lymphocyte proliferation and hematopoietic progenitor colony formation in EAE mice treated with myelin oligodendrocyte glycoprotein.

Authors:  Vasilii B Doronin; Taisiya A Parkhomenko; Alexey Korablev; Ludmila B Toporkova; Julia A Lopatnikova; Alina A Alshevskaja; Sergei V Sennikov; Valentina N Buneva; Thomas Budde; Sven G Meuth; Irina A Orlovskaya; Nelly A Popova; Georgy A Nevinsky
Journal:  J Cell Mol Med       Date:  2015-10-23       Impact factor: 5.310

10.  Production of Abzymes in Th, CBA, and C57BL/6 Mice before and after MOG Treatment: Comparing Changes in Cell Differentiation and Proliferation.

Authors:  Kseniya S Aulova; Andrey E Urusov; Ludmila B Toporkova; Sergey E Sedykh; Yuliya A Shevchenko; Valery P Tereshchenko; Sergei V Sennikov; Thomas Budde; Sven G Meuth; Nelly A Popova; Irina A Orlovskaya; Georgy A Nevinsky
Journal:  Biomolecules       Date:  2019-12-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.